Home

Ursprung Ausweichen Mangel aplidin mechanism of action Zwilling Verräter Messung

New drugs and novel mechanisms of action in multiple myeloma in 2013: a  report from the International Myeloma Working Group (IMWG) | Leukemia
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Leukemia

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting  the host protein eEF1A
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

Generation of endoplasmic reticulum stress and inhibition of autophagy by  plitidepsin induces proteotoxic apoptosis in cancer cells - ScienceDirect
Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in cancer cells - ScienceDirect

AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion  and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK,  and p38 MAPK* - Journal of Biological Chemistry
AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPK* - Journal of Biological Chemistry

Plitidepsin mechanism of action. | Download Scientific Diagram
Plitidepsin mechanism of action. | Download Scientific Diagram

Molecules | Free Full-Text | Approaches to the Potential Therapy of  COVID-19: A General Overview from the Medicinal Chemistry Perspective | HTML
Molecules | Free Full-Text | Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective | HTML

Phamamar achieve to extend the comercialization of its marine derived anti  cancer drugs over eleven latinamerican countries.
Phamamar achieve to extend the comercialization of its marine derived anti cancer drugs over eleven latinamerican countries.

Aplidin in patients with advanced dedifferentiated liposarcomas: a French  Sarcoma Group Single-Arm Phase II study - Annals of Oncology
Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study - Annals of Oncology

Investigational antiviral drugs for the treatment of COVID-19 patients |  SpringerLink
Investigational antiviral drugs for the treatment of COVID-19 patients | SpringerLink

Aplidin synergizes with cytosine arabinoside: functional relevance of  mitochondria in Aplidin-induced cytotoxicity | Leukemia
Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity | Leukemia

Plitidepsin: a potential new treatment for relapsed/refractory multiple  myeloma | Future Oncology
Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma | Future Oncology

Aplidin (plitidepsin) is a novel anti-myeloma agent with potent  anti-resorptive activity mediated by direct effects on osteoclasts. -  Abstract - Europe PMC
Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts. - Abstract - Europe PMC

Plitidepsin: design, development, and potential place in therapy | DDDT
Plitidepsin: design, development, and potential place in therapy | DDDT

Dehydrodidemnin B - an overview | ScienceDirect Topics
Dehydrodidemnin B - an overview | ScienceDirect Topics

Establishment and characterisation of a human carcinoma cell line with  acquired resistance to Aplidin™ | British Journal of Cancer
Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™ | British Journal of Cancer

AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion  and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK,  and p38 MAPK* - Journal of Biological Chemistry
AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPK* - Journal of Biological Chemistry

Frontiers | Exploring the Diversity of the Marine Environment for New  Anti-cancer Compounds | Marine Science
Frontiers | Exploring the Diversity of the Marine Environment for New Anti-cancer Compounds | Marine Science

Aplidin, plitidepsin, as PM90001 | PharmaMar
Aplidin, plitidepsin, as PM90001 | PharmaMar

Activity of Aplidin on MM cell lines. A, dose-response matrix of human... |  Download Scientific Diagram
Activity of Aplidin on MM cell lines. A, dose-response matrix of human... | Download Scientific Diagram

Oncology clinical pipeline marine inspired drugs | PharmaMar
Oncology clinical pipeline marine inspired drugs | PharmaMar

Plitidepsin (Aplidin) targets tumor-associated Nurse-Like cells (NLCs)....  | Download Scientific Diagram
Plitidepsin (Aplidin) targets tumor-associated Nurse-Like cells (NLCs).... | Download Scientific Diagram

Repurposing anticancer drugs for the management of COVID-19 - ScienceDirect
Repurposing anticancer drugs for the management of COVID-19 - ScienceDirect

Plitidepsin | C57H87N7O15 - PubChem
Plitidepsin | C57H87N7O15 - PubChem

Plitidepsin: design, development, and potential place in therapy | DDDT
Plitidepsin: design, development, and potential place in therapy | DDDT

Effect of Aplidin on MM cells stimulated with proliferative cytokines... |  Download Scientific Diagram
Effect of Aplidin on MM cells stimulated with proliferative cytokines... | Download Scientific Diagram

Exploring the effect of aplidin on low molecular weight protein tyrosine  phosphatase by molecular docking and molecular dynamic simulation study -  ScienceDirect
Exploring the effect of aplidin on low molecular weight protein tyrosine phosphatase by molecular docking and molecular dynamic simulation study - ScienceDirect